¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¾Æ»êº´¿ø Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦35Â÷ KSTH Ãá°èÇмú´ëȸ : 2019-05-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¾Æ»êº´¿ø Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦35Â÷ KSTH Ãá°èÇмú´ëȸ : 2019-05-24
±³À°ÀÏÀÚ : 2019-05-24
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø ±³À°¿¬±¸°ü ÁöÇÏ1Ãþ ´ë°­´ç, ¼Ò°­´ç  
±³À°ÁÖÁ¦ : Á¦35Â÷ KSTH Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 042-484-2426  
À̸ÞÀÏ : ksth@thrombo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤½Å°Ç°­ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·á»çȸ½É¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á°æ¿µ, ±âŸ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ïºñ 3¸¸¿ø, Àü°øÀÇ ¹× ±âŸ 1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ09:30~09:50 ´ë±Ô¸ð Àα¸µ¥ÀÌÅÍ º£À̽º·Î º» Çѱ¹ÀÎ ½É¹æ¼¼µ¿°ú NOAC »ç¿ëÀÇ Æ¯¼º  À̼ҷÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ09:50~10:10 2018 ´ëÇѺÎÁ¤¸Æ ÇÐȸ ºñÆǸ·¼º ½É¹æ¼¼µ¿ ȯÀÚÀÇ ³úÁ¹Áß ¿¹¹æ Áöħ  Á¤º¸¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ10:10~10:30 ½ÉÀå ³» Ç÷Àü Çü¼ºÀº Ç÷°ü ³» Ç÷Àü Çü¼º°ú ¾î¶»°Ô ±¸º°µÇ´Â°¡? Journey to the beyond NOACs  ±èÄ¡°æ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ10:30~11:00 ¡°East Asian Paradox¡± and update of recent evidences  ¹Ú°æ¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ11:00~11:30 The role of erythrocyte in arterial thrombosis  À̺´±Ç(¿¬¼¼ÀÇ´ë) 
È޽Ġ05-24  11:30~11:50 break  () 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ11:50~12:10 What¡¯s the optimal antiplatelet strategies in PAD?  °í¿µ±¹(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ12:10~12:30 What¡¯s the role of NOAC in PAD?  ¹Ú»óÈ£(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ12:30~12:50 Current best interventional practice for the treatment of acute VTE  º¯½ÂÀç(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ12:50~13:00 Unmet needs and management strategies on DAPT initiation for ACS patients  ±èÇö±¹(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ13:00~13:10 New treatment option for SGLT2 inhibitor in patients with T2DM  ½ÉµÎ¼±(Àü³²ÀÇ´ë) 
½Ä»ç 05-24  13:10~14:00 Á¡½É½Ä»ç  () 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ14:00~15:00 Poster Oral presentation  ¾È¿µ±Ù(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ15:00~15:30 Patient and anticoagulation dose selection for extended treatment in VTE  ³ª»óÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ15:30~16:00 Balloon pulmonary angioplasty in CTEPH management  °­µµÀ±(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ16:00~16:20 Practical guide for management of splanchnic vein thrombosis  ÀÌÁöÇö(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ16:20~16:40 What is the standard to extend the anticoagulation duration in patient with cancer associated thrombosis?  ÀÓÈ£¿µ(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 05-24 ´ë°­ÀǽǠ16:40~17:00 Is it possible to use DOACs in patients with end-stage renal disease on hemodialysis?  È²Çå±Ô(¼øõÇâÀÇ´ë) 
±âŸ 05-24 ´ë°­ÀǽǠ17:00~17:20 Çмú»ó ¹ßÇ¥ ¹× ½Ã»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¾Æ»êº´¿ø Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦35Â÷ KSTH Ãá°èÇмú´ëȸ : 2019-05-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽÅÀåÇÐȸ KSN 2019 : 2019-05-24
´ÙÀ½±Û ºÎ»ê´ëÇб³º´¿ø ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 5¿ù ¿¬¼ö°­Á : 2019-05-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20934 ÀÎõ 2024³â ´ëÇѵΰæºÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 0 2024-06-14
20933 ¼­¿ï ´ëÇѽɺÎÀüÇÐȸ 2024 ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-15 0 0 2024-06-14
20932 Á¦ÁÖ ´ëÇѸðüžÆÀÇÇÐȸ Á¦30Â÷ Çмú´ëȸ : 2024-06-15 0 0 2024-06-14
20931 Á¦ÁÖ È£³²½½°üÀý¿¬±¸È¸ Á¦76Â÷ Áý´ãȸ : 2024-06-15 0 0 2024-06-14
20930 ¼­¿ï VESC 2024 Ç÷°ü¿Ü°ú Ç÷°ü½Ã¼ú ÄÁÆÛ·±½º (Vascular Endovascular Surgery Conference) : 2024-06-15 0 0 2024-06-14
20929 ¼­¿ï ´ëÇѽŰæ¿Ü°úµðÁöÅÐÀ¶ÇÕ¿¬±¸È¸ Á¦5Â÷ Çмú´ëȸ : 2024-06-15 0 1 2024-06-14
20928 ºÎ»ê 2024³â ºÎ»ê±¤¿ª½Ã »çÇϱ¸ÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-14 0 1 2024-06-14
20927 °æ±â 11th Pan-Pacific Trauma Congress 2024 Korea(Á¦11Â÷ ȯÅÂÆò¾ç±¹Á¦¿Ü»óÇмú´ëȸ)(2ÀÏÂ÷) : 2024-06-14 0 0 2024-06-14
20926 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 1Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 2 2024-06-14
20925 ´ëÀü Á¦34Â÷ ´ëÇѳúÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-14 0 1 2024-06-14
20924 °æ±â 2024 Á¦4ȸ ´ëÇѽŰæ¿Ü°úÇÐȸ ±âÃÊ°úÇבּ¸È¸ Çмú´ëȸ ¹× ÃÑȸ : 2024-06-14 0 2 2024-06-14
20923 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 53 2024-05-28
20922 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 49 2024-05-28
20921 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 48 2024-05-28
20920 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 55 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷